Physician profile
Maria E Gonzalez
NPI 1912988783
$2,286.37
in general payments reported to CMS, 2019-2025
20 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $388 · 2021: $471 · 2022: $125 · 2023: $316 · 2024: $334 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $643.32 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $367.46 | 2019-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $352.16 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $309.22 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $242.04 | 2019-2021 | |
| Abbvie INC. | $50.05 | 2025 | |
| Watermark Medical, INC. | $40.61 | 2021 | |
| Spineology INC. | $34.80 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $30.73 | 2025 | Zoryve |
| Metuchen Pharmaceuticals | $25.93 | 2019 | |
| Coloplast Corp | $23.87 | 2019 | |
| Pfizer INC. | $21.43 | 2024 | |
| Amgen INC. | $21.13 | 2020 | |
| Ardelyx, INC. | $20.85 | 2025 | Ibsrela |
| Xeris Pharmaceuticals, INC. | $20.79 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $19.91 | 2019 | |
| Lupin INC. | $18.24 | 2020 | |
| Exact Sciences Corporation | $16.25 | 2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $16.17 | 2019 | |
| Horizon Therapeutics Plc | $11.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.